Form 4: Oscar Health CTO Sells Shares Under 10b5-1 Plan

Oscar Health's President of Technology and CTO, Mario Schlosser, sold 76,962 shares of Class A Common Stock for $17.01 per share under a pre-arranged trading plan.

Summary

• Mario Schlosser, Oscar Health's President of Technology & CTO and a Director, executed a transaction on January 6, 2026.
• He converted 76,962 shares of Class B Common Stock into Class A Common Stock.
• Simultaneously, he sold 76,962 shares of Class A Common Stock at a weighted average price of $17.01 per share, with individual sales ranging from $17.00 to $17.05.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.
• Following these transactions, Mr. Schlosser directly owns 350,180 shares of Class A Common Stock and 1,455,331 shares of Class B Common Stock (convertible to Class A).
• He also indirectly holds Class B Common Stock through the Noah Pizzo-Schlosser Dynasty Trust (333,333 shares), Pizzo-Schlosser Family Dynasty Trust (633,333 shares), and Siena Pizzo-Schlosser Dynasty Trust (333,333 shares), disclaiming beneficial ownership except for pecuniary interest.

Sentiment

Score: 5

Explanation: The transaction is a pre-scheduled insider sale under a Rule 10b5-1 plan, which is a neutral event as it does not necessarily reflect a change in management's outlook on the company's future performance.

Positives

• The transaction was pre-planned under a Rule 10b5-1 trading plan, indicating a structured approach to managing personal holdings rather than an immediate reaction to company news.
• The sale price of $17.01 per share provides a recent valuation point for a portion of the insider's holdings.

Negatives

• Insider selling, even if planned, reduces the insider's direct stake in the company, which some investors might interpret as a lack of confidence, although this is mitigated by the 10b5-1 plan.

Future Outlook

na

Industry Context

na

Related Party Transactions

• Indirect beneficial ownership of Class B Common Stock is held through the Noah Pizzo-Schlosser Dynasty Trust (333,333 shares), Pizzo-Schlosser Family Dynasty Trust (633,333 shares), and Siena Pizzo-Schlosser Dynasty Trust (333,333 shares). Mr. Schlosser disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.

Key Dates

Recommendation

The transaction is a pre-scheduled sale by an insider under a Rule 10b5-1 plan, which is a common practice for executives to diversify holdings and manage liquidity. It does not inherently signal a change in the company's fundamental outlook or performance, thus a 'hold' recommendation is appropriate unless other fundamental factors suggest otherwise.

Keywords

Oscar Health, OSCR, Mario Schlosser, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CTO, Director, Technology, Healthcare